{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "GBp", "exchange": "LSE", "shortName": "POOLBEG PHARMA PLC ORD 0.02P", "longName": "Poolbeg Pharma PLC", "messageBoardId": "finmb_718912342", "market": "gb_market", "marketState": "CLOSED", "earningsTimestamp": 1680166800, "earningsTimestampStart": 1680166800, "earningsTimestampEnd": 1680166800, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -0.01, "epsForward": -1.28, "epsCurrentYear": -1.19, "priceEpsCurrentYear": -6.3445377, "sharesOutstanding": 500000000, "bookValue": 0.037, "fiftyDayAverage": 7.9264, "fiftyDayAverageChange": -0.3764, "fiftyDayAverageChangePercent": -0.04748688, "twoHundredDayAverage": 7.24866, "tradeable": false, "cryptoTradeable": false, "exchangeTimezoneName": "Europe/London", "exchangeTimezoneShortName": "BST", "gmtOffSetMilliseconds": 3600000, "esgPopulated": false, "regularMarketChangePercent": 0.0, "regularMarketPrice": 7.55, "regularMarketChange": 0.0, "regularMarketTime": 1683905714, "regularMarketDayHigh": 7.8, "regularMarketDayRange": "7.5 - 7.8", "regularMarketDayLow": 7.5, "regularMarketVolume": 310065, "regularMarketPreviousClose": 7.55, "bid": 7.5, "ask": 8.1, "fullExchangeName": "LSE", "financialCurrency": "GBP", "regularMarketOpen": 7.525, "averageDailyVolume3Month": 1121891, "averageDailyVolume10Day": 483004, "fiftyTwoWeekLowChange": 3.5500002, "fiftyTwoWeekLowChangePercent": 0.88750005, "fiftyTwoWeekRange": "4.0 - 11.14", "fiftyTwoWeekHighChange": -3.5900002, "fiftyTwoWeekHighChangePercent": -0.3222621, "fiftyTwoWeekLow": 4.0, "fiftyTwoWeekHigh": 11.14, "twoHundredDayAverageChange": 0.3013401, "twoHundredDayAverageChangePercent": 0.041571837, "marketCap": 37750000, "forwardPE": -0.05898438, "priceToBook": 204.05406, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "averageAnalystRating": "2.0 - Buy", "firstTradeDateMilliseconds": 1626678000000, "priceHint": 2, "symbol": "POLB.L"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "Queen Mary BioEnterprises Innovation Ctr", "address2": "42 New Road", "city": "London", "zip": "E1 2AX", "country": "United Kingdom", "phone": "44 20 7183 1499", "website": "https://www.poolbegpharma.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Poolbeg Pharma plc operates as a biopharmaceutical company in the United Kingdom. It develops POLB 001, a p38 MAP Kinase inhibitor for the treatment of severe influenza; POLB 002, an in\u00adlicensed first\u00adin\u00adclass broad spectrum RNA\u00adbased immunotherapy for respiratory virus infections; and POLB 003, an intramuscular vaccine to prevent Melioidosis. The company also has a licensed access to micro\u00ad and nanoencapsulation technology to develop an oral vaccine delivery platform that delivers immune stimulating antigens to various areas of the gut; and artificial intelligence powered drug program. In addition, it is involved in the development of biomarker platform to identify those at risk of developing severe disease; and vaccine discovery platform, a model-derived discovery platform to identify new vaccine candidates. Poolbeg Pharma plc was incorporated in 2021 and is headquartered in London, the United Kingdom.", "fullTimeEmployees": 12, "companyOfficers": [{"maxAge": 1, "name": "Dr. Jeremy  Skillington Ph.D.", "title": "CEO & Director", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Ian  O'Connell", "title": "CFO & Director", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Carol  Dalton", "title": "VP of Investor Relations & PR", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Salim  Hamir F.C.A.", "title": "Company Sec.", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Ross  Crockett", "title": "Group Financial Controller", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "maxAge": 86400}}], "error": null}}